NCT04297475

Brief Summary

New type of imaging method is in demand clinically for early detection and treatment guiding of RA. Photoacoustic imaging (PAI), a hot spot in medical imaging society, which combines the merits of optical imaging and US and has a capacity in morphological, functional and molecular imaging, has shown potential in visualizing superficial organs, including small joints. The investigators developed a multi-modal photoacoustic/ultrasound (PA/US) imaging system, equipped with a handheld 3D PA/US probe, which wass able to provide 3D volume data of dual-wavelength PA imaging of small joints, in addition to real-time 2D PA/US imaging. The investigators plan to recruit RA patients in different disease conditions and healthy volunteers to receive the 2D and 3D PA/US examination on the 2nd and 3rd MCP, PIP joints and wrist joints using this imaging system, and to evaluate the potential clinical role of the imaging system in RA, and its added value to current imaging methods.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 13, 2019

Completed
8 months until next milestone

First Posted

Study publicly available on registry

March 5, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

October 28, 2020

Status Verified

September 1, 2020

Enrollment Period

3 years

First QC Date

July 13, 2019

Last Update Submit

October 26, 2020

Conditions

Keywords

rheumatoid arthritisultrasonographymulti-modal imagingphotoacoustic imaging

Outcome Measures

Primary Outcomes (2)

  • The PA scores of 50 participants with RA identified by the multi-modal imaging system are in accordance with clinical scoring

    A total of 50 participants received semi-quantitatively measurement of PA signals by the imaging system using a 0-3 scoring system. Score 0 is no PA signals, which represents no detectable active inflammation on PA imaging. Score 1 means less than 3 bars of PA signals within the inflamed regions. Score 2 means multiple PA signals within less than half of the inflammatory lesions. And score 3 means abundant PA signals in over half of the lesions of RA synovium or tenosynovium, which may represent high inflammation activity.

    3-6 months

  • The functional imaging of 60 RA patients assessed by the multi-modal imaging system

    The oxgenation levels of local joint tissues of 60 RA patients are measured by dual-wavelength PA imaging.

    12-15 months

Study Arms (1)

rheumatoid arthritis

The patients are diagnosed with RA according to the American College of Rheumatology (ACR) criteria, and the current clinical state was in-active or relapse. The patients receive final diagnosis and disease evaluation by two experienced rheumatologists

Diagnostic Test: Multi-modal photoacoustic/ultrasonic (PA/US) imaging system

Interventions

The multi-modal PA/US imaging system is equipped with a handheld 3D PA/US probe, and able to provide 3D volume data of dual-wavelength PA imaging of small joints, in addition to real-time 2D PA/US imaging.

rheumatoid arthritis

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The RA patients are diagnosed as RA by two experienced rheumatologists.

You may qualify if:

  • The patients were above 18 years-old;
  • The patients were diagnosed with RA according to the American College of Rheumatology (ACR) criteria, and the current clinical state was in-active or relapse;
  • The patients were consent to receive examinations of photoacoustic imaging.

You may not qualify if:

  • The patients had mental disease or other severe diseases, and were not capable of receiving imaging examinations;
  • The patients had strong reaction to laser light.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, 100730, China

RECRUITING

Related Publications (1)

  • Yang M, Zhao C, Wang M, Wang Q, Zhang R, Bai W, Liu J, Zhang S, Xu D, Liu S, Li X, Qi Z, Yang F, Zhu L, He X, Tian X, Zeng X, Li J, Jiang Y. Synovial Oxygenation at Photoacoustic Imaging to Assess Rheumatoid Arthritis Disease Activity. Radiology. 2023 Jan;306(1):220-228. doi: 10.1148/radiol.212257. Epub 2022 Aug 23.

MeSH Terms

Conditions

Arthritis, Rheumatoid

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Yuxin Jiang, Doctor

    Peking Union Medical College Hospital

    STUDY CHAIR

Central Study Contacts

Meng Yang, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2019

First Posted

March 5, 2020

Study Start

January 1, 2019

Primary Completion

December 31, 2021

Study Completion

December 31, 2022

Last Updated

October 28, 2020

Record last verified: 2020-09

Locations